{"id":48993,"date":"2022-09-29T19:01:59","date_gmt":"2022-09-29T17:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/"},"modified":"2022-09-29T19:01:59","modified_gmt":"2022-09-29T17:01:59","slug":"prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/","title":{"rendered":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast"},"content":{"rendered":"
\n

\nThursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nA look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption<\/i>\n<\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Join PROMETRIKA<\/a> and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience with decentralized clinical trials (DCTs). Mr. Getz and Chelsey Ryan, PMP, Director, Clinical Operations and Pharmacovigilance at PROMETRIKA, will review data on DCT use and discuss the types of studies most suited for virtual and remote support. Participants in the live webcast will have the opportunity to discuss with Mr. Getz how to advance DCTs in clinical research.\n<\/p>\n

\nMr. Getz has enjoyed a 30-year career of providing research and information to clinical trial professionals in the drive to understand and improve clinical research. An internationally recognized expert on clinical trial management practices and trends, Mr. Getz\u2019s studies on protocol design complexity, clinical research efficiency and effectiveness, and the global outsourcing landscape have contributed to an industry-wide understanding of these critical markets. His current research aims to inform the adoption of decentralized clinical trials.\n<\/p>\n

\nMs. Ryan\u2019s extensive 12-year background in leading global clinical research projects has given her the knowledge and insight to translate the many needs of trial stakeholders into unified goals. As the industry embraces decentralization, Ms. Ryan continues to examine the best application of DCT methods to optimize each clinical trial.\n<\/p>\n

\n\u201cWe have gained first-hand experience during the pandemic with, and we\u2019re learning much more about how to optimize the use of, decentralized clinical trial solutions. I\u2019m very excited to be sharing Tufts CSDD data to inform best DCT use practices .\u201d<\/i>\n<\/p>\n

\nKen Getz, MBA
\n
Executive Director and Research Professor
\n
Tufts CSDD\n<\/p>\n

\n\u201c We are thrilled to have Ken Getz speak about his in-depth research on decentralized trials. We hope you will join us! The evening promises a robust discussion on the future of clinical research and the role DCTs will play.\u201d<\/i>\n<\/p>\n

\nMiganush Stepanians, PhD
\n
Founder, President, and CEO
\n
PROMETRIKA, LLC\n<\/p>\n

\nLink to Register to the Live Webcast:<\/b> https:\/\/pages.services\/events.prometrika.com\/Live-Webcast-dct-event-page\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information please contact<\/b>
Kathy Zheng
\n
kzheng@prometrika.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Thursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA A look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption CAMBRIDGE, Mass.–(BUSINESS WIRE)–Join PROMETRIKA and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48993","6":"format-standard","7":"category-industry"},"yoast_head":"\nPROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Thursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA A look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption CAMBRIDGE, Mass.–(BUSINESS WIRE)–Join PROMETRIKA and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T17:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast\",\"datePublished\":\"2022-09-29T17:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005619\\\/en\\\/1575673\\\/21\\\/PMK_OCT13_Webinar_Linkedin_v5.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/\",\"name\":\"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005619\\\/en\\\/1575673\\\/21\\\/PMK_OCT13_Webinar_Linkedin_v5.jpg\",\"datePublished\":\"2022-09-29T17:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005619\\\/en\\\/1575673\\\/21\\\/PMK_OCT13_Webinar_Linkedin_v5.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005619\\\/en\\\/1575673\\\/21\\\/PMK_OCT13_Webinar_Linkedin_v5.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/","og_locale":"en_US","og_type":"article","og_title":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend","og_description":"Thursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA A look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption CAMBRIDGE, Mass.–(BUSINESS WIRE)–Join PROMETRIKA and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-29T17:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast","datePublished":"2022-09-29T17:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/"},"wordCount":377,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/","url":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/","name":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg","datePublished":"2022-09-29T17:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220919005619\/en\/1575673\/21\/PMK_OCT13_Webinar_Linkedin_v5.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/prometrika-presents-exploring-the-impact-of-decentralized-clinical-trials-a-live-webcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials \u2013 A Live Webcast"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48993"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48993\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}